- Home
- VIR vs HBT Comparison
VIR vs HBT Comparison
Compare VIR & HBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- HBT
- Stock Information
- Founded
- VIR 2016
- HBT 1920
- Country
- VIR United States
- HBT United States
- Employees
- VIR N/A
- HBT N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- HBT Major Banks
- Sector
- VIR Health Care
- HBT Finance
- Exchange
- VIR Nasdaq
- HBT Nasdaq
- Market Cap
- VIR 706.4M
- HBT 812.0M
- IPO Year
- VIR 2019
- HBT 2019
- Fundamental
- Price
- VIR $4.80
- HBT $25.80
- Analyst Decision
- VIR Strong Buy
- HBT Buy
- Analyst Count
- VIR 11
- HBT 5
- Target Price
- VIR $25.73
- HBT $29.00
- AVG Volume (30 Days)
- VIR 1.5M
- HBT 22.3K
- Earning Date
- VIR 10-30-2025
- HBT 10-20-2025
- Dividend Yield
- VIR N/A
- HBT 3.32%
- EPS Growth
- VIR N/A
- HBT 8.10
- EPS
- VIR N/A
- HBT 2.42
- Revenue
- VIR $19,000,000.00
- HBT $229,851,000.00
- Revenue This Year
- VIR N/A
- HBT $8.86
- Revenue Next Year
- VIR $11.08
- HBT $2.52
- P/E Ratio
- VIR N/A
- HBT $10.46
- Revenue Growth
- VIR N/A
- HBT 4.61
- 52 Week Low
- VIR $4.16
- HBT $19.46
- 52 Week High
- VIR $14.45
- HBT $27.02
- Technical
- Relative Strength Index (RSI)
- VIR 46.19
- HBT 50.84
- Support Level
- VIR $4.75
- HBT $24.49
- Resistance Level
- VIR $5.39
- HBT $26.43
- Average True Range (ATR)
- VIR 0.30
- HBT 0.62
- MACD
- VIR -0.02
- HBT -0.11
- Stochastic Oscillator
- VIR 5.63
- HBT 51.84
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.